Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Cancer Stories

2014-04-08 12:32:28

Champions TumorGrafts(TM) Provide Accurate Predictions of Treatments' Efficacy in 81 Percent of Evaluated Patients with Advanced Sarcoma HACKENSACK, N.J., April 8, 2014 /PRNewswire/ -- Data published in Cancer show the use of personalized patient-derived xenografts, or mouse avatars, accurately predicted treatment efficacy in all evaluated patients with advanced sarcoma. The results support the predictive capabilities of Champions TumorGrafts®, developed by Champions Oncology (OTC:...

2014-04-08 12:31:41

Study results show correlation between mutational status and treatment response, as well as concordance between BRAF V600E mutation assay and tissue biopsy at baseline SAN DIEGO, April 8, 2014 /PRNewswire/ -- Clinical study results presented today at the American Association for Cancer Research (AACR) Annual Meeting demonstrate the ability of Trovagene's (NASDAQ: TROV) molecular diagnostic platform to detect and monitor BRAF V600E mutations in cancer patients. The results were...

2014-04-08 12:31:26

RICKMANSWORTH, England, April 8, 2014 /PRNewswire/ -- The European Commission has awarded a 1.3M Euro ($1.8M) grant to an international consortium to evaluate a ground-breaking cancer imaging technology. The imaging technology, termed Cerenkov Luminescence Imaging, has the potential to detect cancer during surgery and help ensure that all of the cancerous tissue is removed. The two-year project entitled CLIO will evaluate the imaging technology in patients undergoing...

2014-04-08 12:26:38

RESTON, Va., April 8, 2014 /PRNewswire-USNewswire/ -- inPractice® Resources, LLC, a subsidiary of Clinical Care Options (CCO), today announced the launch of a first-of-its kind education and reference tool dedicated to the needs of all nurses who provide care for patients with cancer. inPractice® Oncology Nursing is a point-of-care tool that combines high-quality nursing-focused content, oncology-specific clinical decision support, patient education, and professional development...

2014-04-08 12:07:17

-NRAS is one of the most studied cancer-related genes. -This study found that the gene produces five variants, not just one form as thought. -The finding might help improve drugs for cancers that involve NRAS. A new study shows that a gene discovered 30 years ago and now known to play a fundamental role in cancer development produces five different gene variants (called isoforms), rather than just the one original form, as thought. The study of the NRAS gene by researchers at The Ohio...

2014-04-08 10:43:57

The difference between an immune response that kills cancer cells and one that conversely stimulates tumor growth can be as narrow as a "double-edged sword," report researchers at the University of California, San Diego School of Medicine in the April 7, 2014 online issue of the Proceedings of the National Academy of Sciences. "We have found that the intensity difference between an immune response that stimulates cancer and one that kills it may not be very much," said principal...

New Prostate Cancer Test May Remove The Need For Painful Biopsies
2014-04-08 09:00:53

April Flowers for redOrbit.com - Your Universe Online Globally, over one million men a year have prostate tissue samples taken to check for signs of prostate cancer. This procedure can involve up to 12 large biopsy needles and has been called barbaric by Mayo Graduate School of Medicine Professor Matthew Gettman. As well, it reveals that 70 percent of the men undergoing the procedure do not have cancer. Beyond being unnecessarily painful and risky for the patient, the procedure is...

2014-04-08 08:30:56

Creative innovator to advance Epic's CTC technology for rapid analysis of cancer for patient matching to clinical trials, therapeutic selection and resistance monitoring SAN DIEGO, April 8, 2014 /PRNewswire/ -- Epic Sciences announced today the appointment of Pascal Bamford, Ph.D. as vice president of product development. Dr. Bamford has more than 15 years of experience in developing complex, automated diagnostic systems for digital pathology. Prior to joining Epic Sciences, Dr....

2014-04-08 08:30:38

Express Scripts Report Forecasts Unsustainable Increases in Specialty Drug Spend ORLANDO, Fla., April 8, 2014 /PRNewswire/ -- Expensive treatments for broad patient populations are driving unprecedented growth in U.S. spending on specialty drugs to treat complex conditions such as rheumatoid arthritis, multiple sclerosis and cancer, according to a new report issued today by Express Scripts (NASDAQ: ESRX). http://photos.prnewswire.com/prnvar/20080827/EXPRESSSCRIPTSLOGO As it has for the past...

2014-04-08 08:30:17

Patent provides protection until 2033 and complements Epizyme's issued composition of matter claims for EZH2 inhibitors CAMBRIDGE, Mass., April 8, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 8,691,507 with claims that cover the identification of patients...


Latest Cancer Reference Libraries

British Journal of Cancer
2012-05-28 10:11:32

The British Journal of Cancer (BJC) is a professional medical journal published biweekly by the Nature Publishing Group (a division of Macmillan Publishers Ltd.) on behalf of Cancer Research UK. It provides a forum for clinicians and scientists to communicate original research findings that have relevance to understanding the etiology of cancer and to improving patient treatment and survival. Papers are published both in print and online. The journal publishes full research papers and...

45_16476fe85b6c94ca2cddefe0d4dea632
2011-02-17 16:45:25

Merkel cell polyomavirus (MCV or MCPyV), first discovered in January 2008, is one of seven human tumor viruses. It is suspected to cause most of Merkel cell carcinoma which is a rare, aggressive form of skin cancer. Around 80% of Merkel cell carcinoma tumors are found to be infected with MCV. It is found in respiratory secretions suggesting that it may be transmitted by a respiratory route. Usually the tumors with MCV viruses go through at least two mutations that render the virus...

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

28_2d79dc61ecefd3449819abf298f2554d
2005-05-26 12:16:31

Asbestos (Greek a-, "not"; sbestos, "extinguishable") is a group of fibrous metamorphic minerals. The name is derived for its historical use in lamp wicks; the resistance of asbestos to fire has long been exploited for a variety of purposes. It was used in fabrics such as Egyptian burial cloths and Charlemagne's tablecloth, which, according to legend, he threw in a fire to clean. When asbestos is used for its resistance to fire or heat, the fibers are typically mixed with cement or woven...

3_ee7b9bf5a8a73941accea20822106ac22
2004-10-19 04:45:40

Cancer Constellation -- The constellation Cancer, the crab, is known in astronomy and astrology as one of the twelve constellations of the zodiac. Cancer is small and dim, and does not resemble a crab. It lies between Gemini to the west and Leo to the east, Lynx to the north and Canis Minor and Hydra to the south. Notable features The brightest star in Cancer is β Cancri, called Al Tarf ("the end" of the crab's leg). Other stars include Acubens (α), and the Aselli (the...

More Articles (5 articles) »